These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 14580963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Filariasis in Africa--treatment challenges and prospects.
    Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S.
    Clin Microbiol Infect; 2011 Jul; 17(7):977-85. PubMed ID: 21722251
    [Abstract] [Full Text] [Related]

  • 3. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU, King CL, Jacobson JA, Weil GJ.
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract] [Full Text] [Related]

  • 4. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J, Basáñez MG, O'Hanlon SJ, Tekle AH, Wanji S, Zouré HG, Rebollo MP, Pullan RL.
    Parasit Vectors; 2018 Jan 31; 11(1):70. PubMed ID: 29382363
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous administration of praziquantel, ivermectin and albendazole, in a community in rural northern Ghana endemic for schistosomiasis, onchocerciasis and lymphatic filariasis.
    Anto F, Asoala V, Anyorigiya T, Oduro A, Adjuik M, Akweongo P, Aborigo R, Bimi L, Amankwa J, Hodgson A.
    Trop Med Int Health; 2011 Sep 31; 16(9):1112-9. PubMed ID: 21689221
    [Abstract] [Full Text] [Related]

  • 6. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct 06; 92(40):594-607. PubMed ID: 28984121
    [No Abstract] [Full Text] [Related]

  • 7. Transmission assessment surveys in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2012 Nov 30; 87(48):478-82. PubMed ID: 23213667
    [No Abstract] [Full Text] [Related]

  • 8. Onchocerciasis and lymphatic filariasis elimination in Africa: it's about time.
    Evans DS, Unnasch TR, Richards FO.
    Lancet; 2015 May 30; 385(9983):2151-2. PubMed ID: 26068266
    [No Abstract] [Full Text] [Related]

  • 9. Short communication: impact of long-term (14 years) bi-annual ivermectin treatment on Wuchereria bancrofti microfilaraemia.
    Kyelem D, Medlock J, Sanou S, Bonkoungou M, Boatin B, Molyneux DH.
    Trop Med Int Health; 2005 Oct 30; 10(10):1002-4. PubMed ID: 16185234
    [Abstract] [Full Text] [Related]

  • 10. The development of albendazole for lymphatic filariasis.
    Horton J.
    Ann Trop Med Parasitol; 2009 Oct 30; 103 Suppl 1():S33-40. PubMed ID: 19843396
    [Abstract] [Full Text] [Related]

  • 11. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2003 May 16; 78(20):171-9. PubMed ID: 12808788
    [No Abstract] [Full Text] [Related]

  • 12. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?
    McCarthy J.
    Am J Trop Med Hyg; 2005 Aug 16; 73(2):232-3. PubMed ID: 16103580
    [No Abstract] [Full Text] [Related]

  • 13. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J, Witt C, Ottesen EA, Lazdins JK, Addiss DG, Awadzi K, Beach MJ, Belizario VY, Dunyo SK, Espinel M, Gyapong JO, Hossain M, Ismail MM, Jayakody RL, Lammie PJ, Makunde W, Richard-Lenoble D, Selve B, Shenoy RK, Simonsen PE, Wamae CN, Weerasooriya MV.
    Parasitology; 2000 Aug 16; 121 Suppl():S147-60. PubMed ID: 11386686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lymphatic filariasis and onchocerciasis.
    Taylor MJ, Hoerauf A, Bockarie M.
    Lancet; 2010 Oct 02; 376(9747):1175-85. PubMed ID: 20739055
    [Abstract] [Full Text] [Related]

  • 17. Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs.
    Mackenzie CD, Geary TG.
    Expert Rev Anti Infect Ther; 2011 May 02; 9(5):497-501. PubMed ID: 21609260
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA, Ismail MM, Horton J.
    Parasitol Today; 1999 Sep 02; 15(9):382-6. PubMed ID: 10461168
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.